Cardiovascular disease management during the coronavirus disease 2019 pandemic

Based on clinical presentation, pathophysiology, high infectivity, high cardiovascular involvement, and therapeutic agents with cardiovascular toxicity of coronavirus disease 2019 (COVID-19), regular cardiovascular treatment is being changing greatly. Despite angiotensin-converting enzyme 2 serving...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wen-Hsien, Chen, Ying-Chih, Chen, Szu-Chia, Chen, Chang-Jen, Hsu, Po-Chao, Tsai, Wei-Chung, Chu, Chun-Yuan, Lee, Chee-Siong, Lin, Tsung-Hsien, Voon, Wen-Chol, Kuo, Chao-Hung, Su, Ho-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330658/
https://www.ncbi.nlm.nih.gov/pubmed/32624690
http://dx.doi.org/10.7150/ijms.46484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330658/
https://www.ncbi.nlm.nih.gov/pubmed/32624690
http://dx.doi.org/10.7150/ijms.46484

Ejemplares similares